Chimeric antigen receptor T-cell therapy in secondary central nervous system lymphoma: A multicenter analysis

Am J Hematol. 2024 Aug;99(8):1624-1627. doi: 10.1002/ajh.27354. Epub 2024 May 20.
No abstract available

Publication types

  • Multicenter Study
  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Central Nervous System Neoplasms* / therapy
  • Female
  • Humans
  • Immunotherapy, Adoptive*
  • Lymphoma / therapy
  • Male
  • Middle Aged
  • Receptors, Chimeric Antigen* / therapeutic use

Substances

  • Receptors, Chimeric Antigen